NYSE:CVS - CVS Health Stock Price, News, & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Thursday, January 3rd. Stockholders of record on Friday, January 25th will be paid a dividend of $0.50 per share on Monday, February 4th. This represents a $2.00 annualized dividend and a dividend yield of 3.13%. The ex-dividend date is Thursday, January 24th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) issued its quarterly earnings data on Tuesday, November, 6th. The pharmacy operator reported $1.73 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.02. The pharmacy operator had revenue of $47.27 billion for the quarter, compared to analysts' expectations of $47.22 billion. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. The company's revenue was up 2.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.50 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for CVS Health.

CVS Health will be holding an earnings conference call on Wednesday, February 20th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

CVS Health issued an update on its FY18 earnings guidance on Tuesday, November, 6th. The company provided EPS guidance of $6.98-7.08 for the period, compared to the Thomson Reuters consensus estimate of $7.04. CVS Health also updated its FY 2018 guidance to $6.98-7.08 EPS.

17 Wall Street analysts have issued twelve-month price targets for CVS Health's stock. Their predictions range from $80.00 to $104.00. On average, they anticipate CVS Health's stock price to reach $92.9375 in the next twelve months. This suggests a possible upside of 45.4% from the stock's current price. View Analyst Price Targets for CVS Health.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 3 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

News articles about CVS stock have trended somewhat negative recently, according to InfoTrie. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. CVS Health earned a media sentiment score of -1.2 on InfoTrie's scale. They also gave news coverage about the pharmacy operator a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the company's share price in the immediate future.

CVS Health saw a decline in short interest during the month of December. As of December 14th, there was short interest totalling 11,357,418 shares, a decline of 67.7% from the November 30th total of 35,182,217 shares. Based on an average daily trading volume, of 12,090,071 shares, the short-interest ratio is presently 0.9 days. Approximately 0.9% of the shares of the stock are sold short. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Diplomat Pharmacy (DPLO), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

CVS Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Retirement Systems of Alabama (0.13%), Hexavest Inc. (0.13%), Factory Mutual Insurance Co. (0.08%), Gateway Investment Advisers LLC (0.08%), Alta Capital Management LLC (0.06%) and Cacti Asset Management LLC (0.04%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Factory Mutual Insurance Co., Alta Capital Management LLC, Gulf International Bank UK Ltd, Endurance Wealth Management Inc., Legacy Advisors LLC, Altfest L J & Co. Inc. and Beacon Financial Group. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, Helena Foulkes, Kevin Hourican, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was purchased by a variety of institutional investors in the last quarter, including Personal Capital Advisors Corp, Gateway Investment Advisers LLC, KAMES CAPITAL plc, Retirement Systems of Alabama, Community Trust & Investment Co., Chesley Taft & Associates LLC, State of Alaska Department of Revenue and Virtu Financial LLC. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $63.92.

CVS Health has a market capitalization of $66.57 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

The official website for CVS Health is http://www.cvshealth.com.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]